147 related articles for article (PubMed ID: 32017943)
21. Inhibitory role of adiponectin peptide I on rat choroidal neovascularization.
Lyzogubov VV; Tytarenko RG; Bora NS; Bora PS
Biochim Biophys Acta; 2012 Aug; 1823(8):1264-72. PubMed ID: 22633972
[TBL] [Abstract][Full Text] [Related]
22. Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization.
Seo S; Suh W
Mol Vis; 2017; 23():823-831. PubMed ID: 29225458
[TBL] [Abstract][Full Text] [Related]
23. Animal models of ocular angiogenesis: from development to pathologies.
Liu CH; Wang Z; Sun Y; Chen J
FASEB J; 2017 Nov; 31(11):4665-4681. PubMed ID: 28739642
[TBL] [Abstract][Full Text] [Related]
24. A novel small molecule ameliorates ocular neovascularisation and synergises with anti-VEGF therapy.
Sulaiman RS; Merrigan S; Quigley J; Qi X; Lee B; Boulton ME; Kennedy B; Seo SY; Corson TW
Sci Rep; 2016 May; 6():25509. PubMed ID: 27148944
[TBL] [Abstract][Full Text] [Related]
25. Nrf2 Activator RS9 Suppresses Pathological Ocular Angiogenesis and Hyperpermeability.
Nakamura S; Noguchi T; Inoue Y; Sakurai S; Nishinaka A; Hida Y; Masuda T; Nakagami Y; Horai N; Tsusaki H; Hara H; Shimazawa M
Invest Ophthalmol Vis Sci; 2019 May; 60(6):1943-1952. PubMed ID: 31050722
[TBL] [Abstract][Full Text] [Related]
26. Brivanib, a multitargeted small-molecule tyrosine kinase inhibitor, suppresses laser-induced CNV in a mouse model of neovascular AMD.
Li L; Zhu M; Wu W; Qin B; Gu J; Tu Y; Chen J; Liu D; Shi Y; Liu X; Sang A; Ding D
J Cell Physiol; 2020 Feb; 235(2):1259-1273. PubMed ID: 31270802
[TBL] [Abstract][Full Text] [Related]
27. Differential hypoxic response of human choroidal and retinal endothelial cells proposes tissue heterogeneity of ocular angiogenesis.
Mammadzada P; Gudmundsson J; Kvanta A; André H
Acta Ophthalmol; 2016 Dec; 94(8):805-814. PubMed ID: 27255568
[TBL] [Abstract][Full Text] [Related]
28. Critical role of caveolin-1 in ocular neovascularization and multitargeted antiangiogenic effects of cavtratin via JNK.
Jiang Y; Lin X; Tang Z; Lee C; Tian G; Du Y; Yin X; Ren X; Huang L; Ye Z; Chen W; Zhang F; Mi J; Gao Z; Wang S; Chen Q; Xing L; Wang B; Cao Y; Sessa WC; Ju R; Liu Y; Li X
Proc Natl Acad Sci U S A; 2017 Oct; 114(40):10737-10742. PubMed ID: 28923916
[TBL] [Abstract][Full Text] [Related]
29. FGF21 Administration Suppresses Retinal and Choroidal Neovascularization in Mice.
Fu Z; Gong Y; Liegl R; Wang Z; Liu CH; Meng SS; Burnim SB; Saba NJ; Fredrick TW; Morss PC; Hellstrom A; Talukdar S; Smith LE
Cell Rep; 2017 Feb; 18(7):1606-1613. PubMed ID: 28199833
[TBL] [Abstract][Full Text] [Related]
30. A potential therapeutic strategy for inhibition of ocular neovascularization with a new endogenous protein: rhEDI-8t.
Zhang L; Shen X; Lu Q; Zhou Q; Gu J; Gan R; Zhang H; Sun X; Xie B
Graefes Arch Clin Exp Ophthalmol; 2012 May; 250(5):731-9. PubMed ID: 21881847
[TBL] [Abstract][Full Text] [Related]
31. Anti-angiogenic effect of caffeic acid on retinal neovascularization.
Kim JH; Lee BJ; Kim JH; Yu YS; Kim KW
Vascul Pharmacol; 2009 Oct; 51(4):262-7. PubMed ID: 19589397
[TBL] [Abstract][Full Text] [Related]
32. The VEGF paradox: Does diabetic retinopathy protect from age related macular degeneration?
Saravia M; Zeman L; Ingolotti M; Schlaen A
Med Hypotheses; 2017 Nov; 109():156-161. PubMed ID: 29150277
[TBL] [Abstract][Full Text] [Related]
33. N-hydroxy-7-(2-naphthylthio) heptanomide inhibits retinal and choroidal angiogenesis.
Kim JH; Kim JH; Oh M; Yu YS; Kim KW; Kwon HJ
Mol Pharm; 2009; 6(2):513-9. PubMed ID: 19718802
[TBL] [Abstract][Full Text] [Related]
34. CNTF Prevents Development of Outer Retinal Neovascularization Through Upregulation of CxCl10.
Bucher F; Aguilar E; Marra KV; Rapp J; Arnold J; Diaz-Aguilar S; Lange C; Agostini H; Schlunck G; Stahl A; Friedlander M
Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):20. PubMed ID: 32780864
[TBL] [Abstract][Full Text] [Related]
35. Secretogranin III as a novel target for the therapy of choroidal neovascularization.
LeBlanc ME; Wang W; Ji Y; Tian H; Liu D; Zhang X; Li W
Exp Eye Res; 2019 Apr; 181():120-126. PubMed ID: 30633921
[TBL] [Abstract][Full Text] [Related]
36. Sustained intraocular vascular endothelial growth factor neutralisation does not affect retinal and choroidal vasculature in Ins2
Lechner J; Hombrebueno JR; Pedrini E; Chen M; Xu H
Diab Vasc Dis Res; 2019 Sep; 16(5):440-449. PubMed ID: 31023085
[TBL] [Abstract][Full Text] [Related]
37. Topical nepafenac inhibits ocular neovascularization.
Takahashi K; Saishin Y; Saishin Y; Mori K; Ando A; Yamamoto S; Oshima Y; Nambu H; Melia MB; Bingaman DP; Campochiaro PA
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):409-15. PubMed ID: 12506103
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of retinal and choroidal neovascularization by a novel KDR kinase inhibitor.
Kinose F; Roscilli G; Lamartina S; Anderson KD; Bonelli F; Spence SG; Ciliberto G; Vogt TF; Holder DJ; Toniatti C; Thut CJ
Mol Vis; 2005 May; 11():366-73. PubMed ID: 15951738
[TBL] [Abstract][Full Text] [Related]
39. Endocan Blockade Suppresses Experimental Ocular Neovascularization in Mice.
Su T; Zhong Y; Demetriades AM; Shen J; Sui A; Yao Y; Gao Y; Zhu Y; Shen X; Xie B
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):930-939. PubMed ID: 29450540
[TBL] [Abstract][Full Text] [Related]
40. Extracellular Protein Fibulin-7 and Its C-Terminal Fragment Have In Vivo Antiangiogenic Activity.
Ikeuchi T; de Vega S; Forcinito P; Doyle AD; Amaral J; Rodriguez IR; Arikawa-Hirasawa E; Yamada Y
Sci Rep; 2018 Dec; 8(1):17654. PubMed ID: 30518776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
